Ghassan Abou-Alfa
@GABOUALFA
@MSKCancerCenter Medical Oncologist, liver, cholangiocarcinoma, gallbladder, biliary cancer specialist. Global healthcare specialist. Patients’ advocate.
05-11-2014 10:11:35
2,4K Tweets
4,7K Followers
1,4K Following
Years, not months. Memorial Sloan Kettering Cancer Center MSK Department of Medicine Ghassan Abou-Alfa present collaborative efforts of Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable #HCC in Annals of Oncology annalsofoncology.org/article/S0923-…